The Romanian Investors Relations Association (ARIR) has recently announced that Farmaceutica REMEDIA (BVB: RMAH) becomes Associate Member. “Present in the Romanian market since 1991 and listed on the Bucharest Stock Exchange for 25 years, Farmaceutica REMEDIA is one of the largest importers and distributors of medicines and medical equipments from Romania,” a press release issued by ARIR informs.
Valentin – Norbert Țăruș (photo), President of the Board of Administrators, Farmaceutica REMEDIA:
”We are focused to adapt business models based on the orientation of the pharma market towards digitalization. We assume the leading role in the Romanian market in the technologizing process, fluidization of processes and development of the pharmaceutical service by implementing robots both at the level of pharmacies and hospitals, as well as pharmaceutical warehouses. Through the partnership with ARIR, we emphasize once again our commitment towards shareholders and investors, as well as towards the innovative concepts – sustainability and digitalization. We want to contribute together with the community of listed companies to the sustainable development of the economy and support improving the interaction with the stakeholders at European level.”
Daniela Șerban, ARIR President & Co-founder:
“We are pleased with the growing representation of the pharma companies in ARIR and the willingness to improve their visibility in the Romanian capital market, as well as the transparency in welcoming investors. Farmaceutica REMEDIA shows continuous progress in communicating with investors, being the company from the Standard category of the Bucharest Stock Exchange with the highest VEKTOR score (9.5). Together we will build new communication milestones with local and international investors.”
Farmaceutica REMEDIA’s mission is launching and promoting innovative pharmaceutical business concepts, offering quality healthcare services adapted to the customers’ needs, respecting the ethical and professional international standards. The company is mainly oriented towards pharmaceuticals distribution, logistics, marketing and promotion activities in the healthcare sector. Farmaceutica REMEDIA is permanently focused on creating “win-win” sustainable competitive advantages and continuously adapts to business partners’ expectations and exigencies.
Farmaceutica REMEDIA is the 29th company to join The Romanian Investors Relations Association.
ARIR members have access to exclusive content for the implementation of best practices in Investor Relations and Corporate Governance, and trainings tailored to their needs and IR objectives, participate at projects aimed to develop the capital market. In ARIR are invited to join: as Associate Members – listed companies, pre-IPO or bond issuers, as Affiliate Members – other companies than the listed ones, pre-IPO or bond issuers, and as Professional Members – individuals with experience in investor relations.
ARIR was founded at the initiative of Daniela Șerban in November 2018 together with the founding members: Bucharest Stock Exchange (BVB), ALRO, Electromagnetica, Franklin Templeton Management – Bucharest office, Hidroelectrica, Nuclearelectrica, Teraplast, Transelectrica, Cosmin Răduță and Tony Romani. Electrica, OMV Petrom, Antibiotice, Purcari, Idea Bank, BRK Financial Group, Banca Transilvania, Transgaz, Biofarm, MedLife and Romcarbon joined the community as Associate Members. INNOVA Project Consulting, ENVISIA, RTPR, Intercapital Invest, eVote and Mazars became Affiliate Members.